Clinical Trials Logo

Crow's Feet clinical trials

View clinical trials related to Crow's Feet.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT03912805 Completed - Crow's Feet Clinical Trials

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Start date: February 27, 2019
Phase: Phase 2
Study type: Interventional

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

NCT ID: NCT03839693 Completed - Clinical trials for Lateral Canthal Lines

ET-01 in Subjects With Lateral Canthal Lines, LCL-208

Start date: October 16, 2018
Phase: Phase 2
Study type: Interventional

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

NCT ID: NCT03655691 Completed - Clinical trials for Lateral Canthal Lines

ET-01 in Subjects With Lateral Canthal Lines, LCL-207

Start date: August 16, 2018
Phase: Phase 2
Study type: Interventional

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

NCT ID: NCT03326856 Completed - Clinical trials for Lateral Canthal Lines

ET-01 in Subjects With Lateral Canthal Lines

Start date: October 25, 2017
Phase: Phase 2
Study type: Interventional

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

NCT ID: NCT01951742 Completed - Clinical trials for Lateral Canthal Lines

Dose Finding Study In Subjects With Crow's Feet

Start date: September 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to establish the therapeutic range of ANT-1401 in the treatment of Crow's Feet.

NCT ID: NCT01358695 Completed - Clinical trials for Lateral Canthal Lines

Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

Start date: May 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of Crow's Feet.

NCT ID: NCT01124565 Completed - Facial Wrinkles Clinical Trials

Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Start date: May 2010
Phase: Phase 2
Study type: Interventional

This study's objective is to evaluate if RT001 is safe and well-tolerated following two (2) sequential applications.

NCT ID: NCT01124552 Completed - Facial Wrinkles Clinical Trials

A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Start date: April 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out if an investigational drug, called RT001 Topical Gel, is safe and useful in minimizing the wrinkles between the eye and hairline called lateral canthal lines, also known as crow's feet wrinkles.

NCT ID: NCT01064518 Completed - Facial Wrinkles Clinical Trials

Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Start date: January 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out if an investigational drug, called RT001 Botulinum Toxin Type A Topical Gel, is safe and useful in minimizing the wrinkles between the eye and hairline called crow's feet, also known as lateral canthal lines.

NCT ID: NCT00968942 Completed - Facial Wrinkles Clinical Trials

Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Start date: August 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of 2 sequential doses of RT001 compared to placebo gel to treat moderate to severe lateral canthal lines in adults.